Experimental in vivo cross-resistance of vinca alkaloid drugs

Related Experiment Video

Updated: Oct 16, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

R Maral, C Bourut, E Chenu

    Cancer Chemotherapy and Pharmacology
    |January 1, 1981
    PubMed

    Abstract:

    In human therapy, an absence of cross-resistance has been observed between vincristine and vindesine in patients receiving polychemotherapy whilst, in our experimental in vivo studies, such a cross-resistance has been found between Vinca alkaloids. Further studies are required to explain this discrepancy.

    More Related Videos

    Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
    08:46

    Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

    Published on: December 9, 2015

    Modeling Chemotherapy Resistant Leukemia In Vitro
    08:41

    Modeling Chemotherapy Resistant Leukemia In Vitro

    Published on: February 9, 2016

    Related Experiment Videos

    Last Updated: Oct 16, 2026

    Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
    09:19

    Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

    Published on: February 6, 2015

    Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
    08:46

    Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

    Published on: December 9, 2015

    Modeling Chemotherapy Resistant Leukemia In Vitro
    08:41

    Modeling Chemotherapy Resistant Leukemia In Vitro

    Published on: February 9, 2016

    Related Concept Videos

    Drugs that Destabilize Microtubules01:10

    Drugs that Destabilize Microtubules

    Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...

    Articles linked to this work by shared authors, journal, and citation graph.

    The Rieske/cytochrome b complex of Heliobacteria.

    Biochimica et biophysica acta·2008

    Relationship between tumour growth rate and carbogen-based functional MRI for a chemically induced HCC in mice.

    Magma (New York, N.Y.)·2004

    [Hypersensitivity pneumonitis in a patient taking pravastatin].

    Revue des maladies respiratoires·2001

    Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13.

    Nature genetics·2001

    [Asbestosis and sarcoid-like thoracic lesions: a case report].

    Revue de pneumologie clinique·2001

    Methylenetetrahydrofolate reductase C677T genotype and venous thromboembolic disease.

    Respiration; international review of thoracic diseases·2000

    The role of tyrosine kinase inhibitors as a post-hematopoietic stem cell transplant continuation therapy for pediatric acute leukemia: a systematic review.

    Cancer chemotherapy and pharmacology·2026

    Irinotecan induces intestinal atrophy and compromises duodenal motility and mucosal permeability: in vivo and in vitro evaluations.

    Cancer chemotherapy and pharmacology·2026

    Translational applications and clinical utility of organoids in ovarian cancer: a systematic review.

    Cancer chemotherapy and pharmacology·2026

    Protective effect of N-acetylcysteine on oxaliplatin-induced peripheral neuropathy in colorectal cancer: a randomized controlled trial.

    Cancer chemotherapy and pharmacology·2026

    Successful treatment with BrECADD in a patient with Dubin-Johnson syndrome and classic Hodgkin lymphoma: a case report.

    Cancer chemotherapy and pharmacology·2026

    Biological frailty and chemotherapy dose intensity independently predict survival in older adults with Stage II-III colon cancer.

    Cancer chemotherapy and pharmacology·2026

    Anti-neoplastic effects of Chrysanthemum indicum extract on a human hypopharyngeal squamous cell carcinoma cell line.

    Oncology letters·2026

    DCST1 drives cisplatin resistance via non-canonical ubiquitination and stabilization of NFAT5 to suppress PANoptosis in bladder cancer.

    Cell death and differentiation·2026

    Indazole Derivatives as Emerging Scaffolds for Anti-Breast Cancer Therapy: Synthesis, Structure-Activity Relationship, and Therapeutic Potential.

    Archiv der Pharmazie·2026

    Advanced Anal Squamous Cell Carcinoma in the Chemoimmunotherapy Era: Retifanlimab, Nivolumab, and a Practical Framework for Treatment Selection.

    Journal of gastrointestinal cancer·2026

    Longitudinal changes in gut microbial evenness and dominance during anti-CD20-containing chemoimmunotherapy with concurrent trimethoprim-sulfamethoxazole prophylaxis in patients with B-cell lymphoma.

    Immunological medicine·2026

    Coixol, a benzoxazolinone derived from coix seed, ameliorates disordered hepatocellular programmed responses in alcoholic-associated liver disease.

    Natural product research·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us